Episurf Medical AB (publ) EPIS-B.ST
EPIS-B.ST
Episurf Medical AB (publ) QLIFE.ST
Qlife Holding AB (publ) PROGEN.ST
Prostatype Genomics AB (publ) CMH.ST
Chordate Medical Holding AB (publ) SPERM.ST
Spermosens AB AINO.ST
Aino Health AB (publ) FLUI.ST
Fluicell AB (publ) ODI.ST
ODI Pharma AB 2CUREX.ST
2cureX AB (publ) MODTX.ST
Modus Therapeutics Holding AB (publ)
Episurf Medical AB (publ) QLIFE.ST
Qlife Holding AB (publ) PROGEN.ST
Prostatype Genomics AB (publ) CMH.ST
Chordate Medical Holding AB (publ) SPERM.ST
Spermosens AB AINO.ST
Aino Health AB (publ) FLUI.ST
Fluicell AB (publ) ODI.ST
ODI Pharma AB 2CUREX.ST
2cureX AB (publ) MODTX.ST
Modus Therapeutics Holding AB (publ)
Performance
| Periode | EPIS-B.ST | QLIFE.ST | PROGEN.ST | CMH.ST | SPERM.ST | AINO.ST | FLUI.ST | ODI.ST | 2CUREX.ST | MODTX.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -58.54 % | 5.77 % | -66.38 % | -9.11 % | -24.44 % | 4.52 % | 15.97 % | -40.19 % | 158.45 % | -64.77 % |
| YTD | -64.58 % | 5.77 % | -93.50 % | -45.06 % | -48.48 % | -13.33 % | -37.22 % | -48.80 % | 282.50 % | -74.38 % |
| 1Y | -66.04 % | -9.09 % | -94.84 % | -87.43 % | -68.81 % | 73.33 % | -43.35 % | -59.75 % | 175.68 % | -68.24 % |
| 3Y | -97.32 % | -99.98 % | -99.90 % | -98.84 % | -99.82 % | -10.99 % | -98.57 % | -74.50 % | -82.57 % | -78.42 % |
| 5Y | -97.73 % | -99.99 % | -99.97 % | -98.86 % | -99.91 % | -77.55 % | -99.51 % | -73.44 % | -90.10 % | -91.41 % |
| 10Y | -99.56 % | -99.99 % | -99.97 % | -98.86 % | -99.91 % | -98.27 % | -99.74 % | -86.89 % | -79.89 % | -91.41 % |
| From the beginning | -99.28 % | -99.99 % | -99.97 % | -98.86 % | -99.91 % | -98.27 % | -99.74 % | -86.89 % | -79.89 % | -91.41 % |